111 related articles for article (PubMed ID: 9675561)
21. [Comparative randomized controlled study between human follicle- stimulating hormone (FSH-HP) and human menopausal gonadotropins (hMG) in in vitro fertilization].
Mayenga JM; Belaisch-Allart J; Chouraqui A; Tesquier L; Serkine AM; Cohen J; Plachot M; Mandelbaum J
Contracept Fertil Sex; 1997 May; 25(5):371-4. PubMed ID: 9273107
[TBL] [Abstract][Full Text] [Related]
22. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
23. Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression.
Edelstein MC; Brzyski RG; Jones GS; Simonetti S; Muasher SJ
Fertil Steril; 1990 Jan; 53(1):103-6. PubMed ID: 2104806
[TBL] [Abstract][Full Text] [Related]
24. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin.
Imthurn B; Macas E; Rosselli M; Keller PJ
Hum Reprod; 1996 Nov; 11(11):2387-91. PubMed ID: 8981116
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone.
Sills ES; Schattman GL; Veeck LL; Liu HC; Prasad M; Rosenwaks Z
Fertil Steril; 1998 May; 69(5):831-5. PubMed ID: 9591488
[TBL] [Abstract][Full Text] [Related]
26. Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG.
Fried G; Harlin J; Csemiczky G; Wramsby H
Hum Reprod; 1996 Mar; 11(3):474-7. PubMed ID: 8731179
[TBL] [Abstract][Full Text] [Related]
27. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis.
Karnitis VJ; Townson DH; Friedman CI; Danforth DR
J Clin Endocrinol Metab; 1994 Jul; 79(1):91-7. PubMed ID: 8027261
[TBL] [Abstract][Full Text] [Related]
29. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration.
Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Spettoli D; Taraborrelli S; Ciampaglia W
Hum Reprod; 2002 Aug; 17(8):2009-15. PubMed ID: 12151429
[TBL] [Abstract][Full Text] [Related]
30. Antagonist protocol versus clomiphene in unexplained infertility: A randomized controlled study.
Nada AM; ElSetohy KA; Banat MM; Shaheen AF
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):326-30. PubMed ID: 27343309
[TBL] [Abstract][Full Text] [Related]
31. Induction of ovulation for gamete intrafallopian transfer (GIFT) using a gonadotropin-releasing hormone agonist and "pure" FSH: results obtained in 30 normally menstruating women.
La Sala GB; Cantarelli M; Parolari G; Dessanti L; Dall'Asta D; Torelli MG; Salvatore V; Dotti C; Cavalieri S; Brai L
Acta Eur Fertil; 1988; 19(3):159-65. PubMed ID: 3147563
[TBL] [Abstract][Full Text] [Related]
32. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes.
Kilani Z; Dakkak A; Ghunaim S; Cognigni GE; Tabarelli C; Parmegiani L; Filicori M
Hum Reprod; 2003 Jun; 18(6):1194-9. PubMed ID: 12773445
[TBL] [Abstract][Full Text] [Related]
33. Controlled ovarian stimulation using a long gonadotropin-releasing hormone antagonist protocol: a proof of concept and feasibility study.
Weissman A; Ravhon A; Steinfeld Z; Nahum H; Golan A; Levran D
Gynecol Obstet Invest; 2013; 76(2):113-8. PubMed ID: 23920048
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of a combination administration of gonadotropin-releasing hormone agonist and gonadotropins for controlled ovarian hyperstimulation in IVF program.
Chang YS; Kim SH; Shin CJ; Kim JG; Moon SY; Lee JY
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):337-45. PubMed ID: 2129188
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
Andersen AN; Devroey P; Arce JC
Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
[TBL] [Abstract][Full Text] [Related]
37. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
Balasch J; Fábregues F; Creus M; Peñarrubia J; Vidal E; Carmona F; Puerto B; Vanrell JA
J Assist Reprod Genet; 2000 Jan; 17(1):20-7. PubMed ID: 10754779
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
Bühler KF; Fischer R; Verpillat P; Allignol A; Guedes S; Boutmy E; Bilger W; Richter E; D'Hooghe T
Reprod Biol Endocrinol; 2021 Jun; 19(1):90. PubMed ID: 34134695
[TBL] [Abstract][Full Text] [Related]
39. Do the suppression criteria in GnRH-a cycles predict in vitro fertilization outcome?
Senöz S; Gülekli B; Turhan NO; Ozakşit G; Odabaşi AR; Oral H; Ozcan U; Gökmen O
Gynecol Endocrinol; 1995 Jun; 9(2):91-6. PubMed ID: 7502695
[TBL] [Abstract][Full Text] [Related]
40. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study.
Westergaard LG; Erb K; Laursen SB; Rex S; Rasmussen PE
Fertil Steril; 2001 Sep; 76(3):543-9. PubMed ID: 11532479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
